A CES 2024 preview, 23andMe victim blaming and MIT’s obesity-fighting pill
Welcome, folks, to Week in Review (WiR), TechCrunch’s regular newsletter that recaps the week in tech that was. Hope the holidays were restful for those who observed them. We at TC, for our parts, are gearing up for an eventful next week at CES in Las Vegas — while keeping an eye on the news … Read more